Mediation between Bayer, plaintiffs seeks to clarify all justified claims: US mediator

Bayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other glyphosate-based weed killers as part of its $63 billion take over of Monsanto last year, faces potentially heavy litigation costs as plaintiffs claim Roundup causes cancer, something Bayer disputes.

New Delhi: Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg told a German magazine.

"The mediation is going slowly but steadily," Wirtschaftswoche on Wednesday quoted Feinberg as saying.

Read Also: Bayer Roundup suits increase to 42700

Bayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other glyphosate-based weed killers as part of its $63 billion takeover of Monsanto last year, faces potentially heavy litigation costs as plaintiffs claim Roundup causes cancer, something Bayer disputes.

Read Also: Bayer inks deals with 11 startups under G4A to develop new digital health solutions